| Yang, Jun Ying |
NCT02938741: ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors |
|
|
| Recruiting | 4 | 130 | RoW | Anti-human Thymoglobulin, (r-ATG ）, Placebo | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Lymphoblastic Lymphoma | 12/21 | 12/22 | | |
| Completed | 3 | 295 | Europe, US, RoW | Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg, Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, Placebo | George Medicines PTY Limited | Hypertension | 09/23 | 10/23 | | |
GMRx2_ACT, NCT04518293: Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension |
|
|
| Completed | 3 | 1385 | Europe, US, RoW | Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg, Telmisartan 20 mg/amlodipine 2.5 mg ., telmisartan 40 mg/amlodipine 5 mg, Telmisartan 20 mg/indapamide 1.25 mg, telmisartan 40 mg/indapamide 2.5 mg, Amlodipine 2.5 mg/indapamide 1.25 mg, amlodipine 5 mg/indapamide 2.5 mg | George Medicines PTY Limited | Hypertension | 08/23 | 09/23 | | |
NCT06198764: A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection |
|
|
| Recruiting | 3 | 80 | RoW | Colistimethate sodium for injection, Meropenem for Injection, Coly Mycin M Injectable Product | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Mental Health Issue | 03/26 | 03/26 | | |
NCT06138353: Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS) |
|
|
| Recruiting | 2/3 | 50 | RoW | Shuxuening injection or placebo | Xiaolin Chen, MD | Subarachnoid Hemorrhage, Aneurysmal | 11/25 | 11/25 | | |
NCT04409080 / 2020-002031-29: REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy |
|
|
| Suspended | 1/2 | 33 | Europe, US, RoW | REGN7257 | Regeneron Pharmaceuticals, Regeneron Pharmaceuticals, Inc | Severe Aplastic Anemia (SAA) | 01/26 | 07/26 | | |
NCT04881981: A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer |
|
|
| Not yet recruiting | 1 | 12 | US, RoW | SCART radiation therapy | Baptist Health, Louisville, Drexel University, Innovative Institute, University of Kentucky, Foshan Chancheng Hospital | Malignant Neoplasms | 05/22 | 05/22 | | |
| Recruiting | 1 | 96 | RoW | BL-B01D1 | Sichuan Baili Pharmaceutical Co., Ltd., SystImmune Inc. | Locally Advanced or Metastatic Solid Tumor | 06/25 | 12/25 | | |
NCT06417502: Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry |
|
|
| Recruiting | N/A | 20000 | RoW | | Peking Union Medical College Hospital, Children's Hospital of Chongqing Medical University, Central South University, Beijing Children's Hospital, Shenzhen Children's Hospital, Children's Hospital of Nanjing Medical University, The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Zhejiang University, Third Hospital of Peking University | Autoimmune Diseases, Autoinflammatory Diseases | 11/24 | 12/31 | | |
NCT06210100: aiTBS for NSSI and Suicide in Adolescent Depression |
|
|
| Recruiting | N/A | 60 | RoW | Active iTBS, Sham iTBS | Central South University | Non Suicidal Self Injury, Suicidal Ideation, Suicide and Self-harm | 12/24 | 02/25 | | |
| Not yet recruiting | N/A | 60 | NA | Gamma Entrainment Stimulation, Audio-assistied therapy | Beijing Tiantan Hospital, Shanghai Joyingmed Sensory Stimulation Lab | Subarachnoid Hemorrhage, Aneurysmal, Cognitive Dysfunction | 03/25 | 03/25 | | |
TRIPHY, NCT06480890: Real-World Effectiveness of a Triple Combination BDP/FF/GB in a Single Pressurised Metered Dose Inhaler in COPD Patients |
|
|
| Recruiting | N/A | 359 | RoW | | Chiesi Farmaceutici S.p.A. | Chronic Obstructive Pulmonary Disease | 10/25 | 10/25 | | |
| Recruiting | N/A | 190 | RoW | Imatinib, treat | Xijing Hospital | GIST | 09/24 | 09/25 | | |
NCT00730678: Pharmacogenetic Determinants Of Treatment Response In Children |
|
|
| Recruiting | N/A | 8800 | US | | St. Jude Children's Research Hospital, National Cancer Institute (NCI), National Institute of General Medical Sciences (NIGMS) | All Malignancies, Children Being Treated for Catastrophic Illness | 12/33 | 03/34 | | |
